E
Eugene Braunwald
Researcher at Brigham and Women's Hospital
Publications - 1758
Citations - 278949
Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial.
David A. Morrow,Elliott M. Antman,Assaad Sayah,Kristin C Schuhwerk,Robert P. Giugliano,James deLemos,Michael Waller,Sidney Cohen,Donald Rosenberg,Sally S. Cutler,Carolyn H. McCabe,Ron M. Walls,Eugene Braunwald +12 more
TL;DR: Prehospital administration of rPA is a feasible approach to accelerating reperfusion in patients with STEMI and valuable time savings can be achieved in the setting of contemporary transport and door-to-drug times and may translate into an improvement in clinical outcomes.
Journal ArticleDOI
Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study.
Olga Iakoubova,Marc S. Sabatine,Charles M. Rowland,Carmen H. Tong,Joseph J. Catanese,Koustubh Ranade,Katy L. Simonsen,Todd G. Kirchgessner,Christopher P. Cannon,James J. Devlin,Eugene Braunwald +10 more
TL;DR: Carriers of 719Arg receive significantly greater benefit from intensive statin therapy than do noncarriers, a superior benefit that appears to be due to a mechanism distinct from lipid or CRP lowering.
Journal ArticleDOI
Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Theraphy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial
David A. Morrow,David A. Morrow,Yunmei Wang,Kevin Croce,Masashi Sakuma,Marc S. Sabatine,Huiyun Gao,Aruna D. Pradhan,Aileen M. Healy,Jacki Buros,Carolyn H. McCabe,Peter Libby,Peter Libby,Christopher P. Cannon,Christopher P. Cannon,Eugene Braunwald,Eugene Braunwald,Daniel I. Simon +17 more
TL;DR: In this paper, the authors used a transcriptional profiling approach to identify myeloid-related protein 8/14 (MRP-8/14) to be expressed by platelets during acute myocardial infarction (MI).
Journal ArticleDOI
Atrial Failure as a Clinical Entity: JACC Review Topic of the Week
TL;DR: The term atrial failure is proposed as a clinically relevant entity, defined as any atrial dysfunction causing impaired heart performance, symptoms, and worsening quality of life or life expectancy.
Journal ArticleDOI
Effect of the Novel Thienopyridine Prasugrel Compared With Clopidogrel on Spontaneous and Procedural Myocardial Infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38 An Application of the Classification System From the Universal Definition of Myocardial Infarction
David A. Morrow,Stephen D. Wiviott,Harvey D. White,Jose C. Nicolau,Ezio Bramucci,Sabina A. Murphy,Marc P. Bonaca,Christian T. Ruff,Benjamin M. Scirica,Carolyn H. McCabe,Elliott M. Antman,Eugene Braunwald +11 more
TL;DR: In this paper, the authors compared prasugrel with clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention, and found that the latter significantly reduced the risk of myocardial infarction.